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7.1  Introduction
E-prescription was introduced in Greece during times of financial turbulence with 
the aim to enhance control over pharmaceutical expenditure and also, to improve 
doctor-pharmacy collaboration and patient safety and to support evidence-based 
policy development. In that sense, the introduction of e-prescription is not yet 
another technology project but rather, a socio-technical intervention with infrastruc-
tural nature. In this chapter we explore the national e-prescription service’s surpris-
ingly swift deployment. Specifically, we identify how a series of pragmatic tactical 
decisions allowed building upon a “good-enough” installed base by exploiting its 
latent potential without perpetuating all of its weaknesses. Furthermore, we show 
how hedging against obsolescence was practiced through continuously addressing 
exogenous shifts in the installed base. Finally, we point to the pivotal role of the 
technical architecture implemented for enabling installed base cultivation. A com-
bination of novel technological affordances, standards and architectural patterns 
made possible the development of a technical solution which supports openness, 
evolvability and scalability.
In our study we position e-prescribing within the overall Greek health system 
and we describe how the new electronic service evolved to inscribe specific 
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prescribing policies, to provide clinical decision support, and to facilitate the pro-
cesses and roles of policy and financing stakeholders. Our case description spans 
the period from 2010 to 2015.
The remaining of the chapter is structured as follows: in Sect. 7.2 we present 
an overview of the Greek healthcare system and the situation with respect to infor-
mation systems, in Sect. 7.3 we present the rationale for the introduction of 
e- prescription in Greece, we provide an overview of the e-prescription service and 
we describe its evolution over time, then, in Sect. 7.4 we discuss the relationship 
to the installed base. Finally, in Sect. 7.5 we provide some concluding remarks.
7.2  Healthcare in Greece
7.2.1  Overview of the Greek Healthcare System
Healthcare delivery in Greece is based on both public and private providers (mainly 
in primary care and diagnostic tests). The Greek national health system (ESY) was 
established after a major healthcare reform in 1983 with the aim to guarantee uni-
versal healthcare coverage for all (universal healthcare rights are stipulated by the 
Greek Constitution). Public health provision is coordinated by seven Health Regions 
that are supervised by the Ministry of Health. Secondary healthcare is provided by 
public and private hospitals and clinics. Primary healthcare is provided through 
rural health centers and provincial surgeries in rural areas, the outpatient depart-
ments of regional and district hospitals in urban areas and contracted doctors with 
private practices (OECD 2013a). Unlike what is common in many other European 
countries, Greek residents do not have to register with General Practitioners (GPs) 
and GPs do not have a gate-keeping role. Individuals can access the entire spectrum 
of specialists for consultations and can be directly referred by them for reimbursable 
Data Collection
To (re)construct e-prescription’s trajectory: extensive documents’ review 
including legislation and guidelines, policy documents and strategic plans, 
press releases (from Social Security Funds, the Ministry of Health, and 
IDIKA), public consultation documents, presentation documents from vari-
ous professional and academic events, posts in professional electronic forums, 
articles in specialised press and journals.
To develop an understanding of the e-prescription solution: on-site obser-
vations of e-prescription use in pharmacies. The observations were repeated 
in 2 month intervals. Additionally, we studied the user manuals for pharma-
cists and doctors.
To elicit practitioners’ perspectives: seven semi-structured interviews.
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tests and examinations. Because of the structure of healthcare provision, and the 
lack of a GP referral system, free choice of provider is a key characteristic of the 
system. The ownership of pharmacies is limited to pharmacists. Pharmacies are 
licensed by the government on the basis of criteria for population coverage and 
distance from the nearest existing pharmacy.
Key health indexes for the Greek population are good. In the 2000 report by the 
World Health Organization on health systems’ performance, the Greek healthcare 
system was ranked 14th worldwide in terms of overall performance and 11th on 
level of health (World Health Organization 2000). During recent years, healthcare 
cost containment has been the main Government’s concern. This concern is induced 
both by the rise in healthcare services demand (due to the aging population, the 
increase of patients living with chronic conditions and citizens’ pressures for 
increasing the supply of quality healthcare services) but also, by the need to address 
the ongoing public debt crisis.
As in nearly all European countries, the public sector is the main source of 
healthcare financing. Financing is provided mainly by social security funds 
(although out-of-pocket-payments and direct health financing from the national 
budget of the central government are also significant). Most of the funds are pub-
lic entities (legal persons governed by public law), and while they are autono-
mous, they operate under the control of central government. The funds cover both 
pensions and healthcare for particular socio-professional groups (i.e. there are 
different funds for farmers, public servants, etc.) on the basis of personal contri-
butions but the state also contributes to their financing. The number of funds was 
brought down from 130 to 13 in 2008 (OECD 2013a) and there is further consoli-
dation underway. For healthcare, the aim is to merge all healthcare coverage 
schemes (that relate to different funds) to a single one. On March 2011, the health-
care schemes for farmers, freelance non-professional workers and public servants 
were subsumed by the scheme for non-public sector salaried employees (IKA). 
All together came under the umbrella of a new organisation named “National 
Organisation for Health Services Provision” (EOPYY, incorporated with Law 
3918/2011) which started operating in 2012. EOPYY is still being expanded to 
cover the beneficiaries of all other social insurance funds and is gradually becom-
ing a single public buyer of healthcare goods and services. Figure 7.1 provides an 
overview of the main actors involved in healthcare regulation, provision and 
financing.
Aggregate public spending for health is moderate compared to EU and OECD 
averages (OECD 2013b). Although the overall expenditure is moderate, the sta-
tistics indicate room for improvement especially within pharmaceuticals where 
the annual expenditure both per capita and as a share of the Gross Domestic 
Product is high (about 40% more than the EU average) (OECD 2013b). This 
high expenditure has been a key concern for the Government also because health 
goods are predominantly financed by public funds (74% of expenditure is pub-
licly financed in Greece while only 54% in Europe as an average (OECD 
2013b)).
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7.2.2  Information Systems in Greek Healthcare
Initial efforts for the introduction of information systems within Greek health-
care date back to the 1980s (Fragidis and Chatzoglou 2011). Nevertheless, 
although a series of national plans were drafted and pursued (e.g. most recently, 
the national 2002–2006 Action Plan “ICT in healthcare” and the national 
eHealth roadmap 2006–2015), the progress achieved has not always been 
significant.
Notwithstanding the delays, there has been a clear positive trend in information 
systems’ use over the years. Practically all pharmacies use information systems. 
Within primary care, as of 2013, 99% of GP practices had computers in the consul-
tation room as opposed to only 66% back in 2007, 99% of practices were connected 
to the internet or a dedicated GP network and 24% had their own website (European 
Commission DG Communications Networks Content and Technology 2013). The 
electronic storage of medical patient data is relatively common among GPs although 
it is not universally exercised: around 70% of GPs store electronically the medical 
history of their patients and more than 60% register electronically their clinical 
notes, symptoms and ordered tests (idem). Health information exchange is much 
less developed among GPs (idem): only around 22% receive laboratory reports 
electronically and around 20% exchange medical patient data with other healthcare 
Ministry of health
7 health
regions
National Organisation
for Medicines (EOF)
& other
special purpose
organisations
Public rural health
centers &
provincial surgeries
Contracted specialists
Public hospitals
Private hospitals and
clinics
Private laboratories and
diagnostic centers
Privately owned
pharmacies
National budget
Direc
t pay
ment
s
Use-based
payment
flows
Direct payments
Direct payments
National Organisation
for Health Services
Provision (EOPYY)
Social
security
funds
Private
insurance
Patients’
own funds
(out of pocket)
Healthcare regulation
H
ea
lt
h
ca
re
 p
ro
vi
si
o
n
H
ealth
care fin
an
cin
g
Fig. 7.1 Greek healthcare: regulation, financing and service provision (as of 2015)
P. Vassilakopoulou and N. Marmaras
93
providers and professionals (excluding prescriptions), electronic interactions with 
patients are also limited (27% of GPs).
As of 2013, practically all hospitals (99%) used computer systems; billing man-
agement (90%) and discharge letters (76%) were the most common hospital appli-
cations (European Commission Joint Research Centre Institute for Prospective 
Technological Studies (JRC-IPTS) 2014). Hospital-wide electronic health record 
systems shared by all clinics were used in around half of the hospitals (52%) another 
13% used multiple local systems, while 35% had no health record system in place 
(idem). Only 24% of hospitals exchanged health information (excluding prescrip-
tions) with entities outside the hospital (e.g. other hospitals, external specialists, 
GPs) (idem).
Medical data exchange has been impeded by the lack of a single personal 
identifier for all Greek residents up till recently (the obligatory social security 
number – AMKA was only introduced in October 2009 (Greek Ministry for 
Labour 2012)), the delays in establishing a secure network (the secure network 
“Syzefxis” that connects all public entities including healthcare was only initi-
ated in 2004, became operational in 2006 and it is still under development 
although it has now achieved significant coverage) and the multitude of solutions 
with different logics and limited standardization (Emmanouilidou and Burke 
2012; Bogdanos et al. 2008).
7.3  The Introduction of E-Prescription
7.3.1  Rationale for E-Prescription and Key Milestones
Greece introduced e-prescription to enhance control over pharmaceutical expendi-
ture, to improve doctor-pharmacy collaboration and patient safety and to capture 
data required for evidence-based policy development. The aspired benefits were 
clearly set-out in the law that provides the legal basis for e-prescription (Law 
3892/2010). The year when the e-prescription law passed (year 2010) the Greek 
economy was facing a severe public debt crisis which captured global attention. In 
return for loans from the International Monetary Fund and European Institutions, 
the Greek government agreed to accelerate reforms including structural reforms of 
the healthcare sector and the introduction of new electronic tools. The strong finan-
cial motivation behind the e-prescription initiative is demonstrated by its inclusion 
in May’s 3rd 2010 “Memorandum of Economic and Financial Policies” between 
Greece and the International Monetary Fund and subsequently in the “Hellenic 
National Reform Programme 2011–2014” issued on April 2011.
The introduction of e-prescription was swift: development started in 2010, a 
pilot was run in October of the same year and the official launch was on January 
24th 2011 (Table 7.1). By the fall of 2011 around 40% of prescriptions were cov-
ered, and by fall 2013 almost full coverage was reached (Papanikolaou 2013). 
E-prescription was one of the initiatives that contributed to the reduction of the 
total pharmaceuticals’ expenditure by approximately 33% between the years 2009 
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and 2011 (Greek e-Government Centre for Social Security 2011). In the next sec-
tions we present the trajectory followed starting with a brief presentation of the 
situation before the introduction of the new electronic service.
7.3.2  Information Handling Before the Introduction 
of E-Prescription
Before the introduction of e-prescription prescribing was supported by “prescrip-
tion booklets” issued by Greek social security funds. These booklets were kept by 
the patients and used during their interactions with doctors and pharmacists. The 
booklets were personalised: they contained a photo, identity information such as 
name, birth date, address, registration id (for the fund’s internal registry), national 
tax id and a unique identification number per booklet. Each booklet contained fifty 
double-sided prescription pages and their carbon copies (a white coloured original 
and a yellow coloured copy). Each prescription page had on the one side fields to be 
used by the prescribing doctor (including doctors’ information, diagnosis, drugs 
description and quantity) and by the dispensing pharmacist (including pharmacist 
information, drugs’ cost and patient’s cost share) and on the other side a template for 
attaching identifying adhesive labels from the packaging of the drugs dispensed. 
These labels are mandatory for all drugs circulating in Greece. Drugs carry a serial 
number that identifies each pack uniquely. Serial numbers are used for preventing 
reimbursement fraud and monitoring consumption and expenditure. The booklet 
format was defined in 1998 (presidential decree 82A/1998) and revised in 2008 to 
include the national insurance number (AMKA) and a barcode. Figure 7.2 presents 
the standard prescription template that was in use before the introduction of 
e-prescription.
Table 7.1 Greek e-prescription: key facts
Function Users Temporal evolution
Guide prescribing 
behaviour, support 
registration and circulation 
of prescription and 
dispensing information
General practitioners 
and specialists in 
primary care, private 
and public hospitals
Initiated in 2010
Launched in January 2011  
(pilot October 2010)
Pharmacists
Reimbursing 
authorities
Almost full coverage (98%) by 2013
Public health policy 
makers
Fall 2010 
(pilot)
Fall 2011 Fall 2012 Fall 2013
Pharmacists ~8,500 ~8,500 ~10,800 ~10,800 (98% of total)
Doctors ~4,100 ~10,100 ~37,500 ~41,000 (90% of total)
Prescriptions 
(monthly)
~8000 ~2,500,000 ~4,500,000 ~6,000,000  
(98% of total)
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Patients carried with them their prescription booklets when visiting a doctor. 
Doctors would use a page for prescribing drugs, sign and stamp the page and 
hand the booklet back to patients. Afterwards, patients could visit any phar-
macy, hand the booklet to the pharmacist who would then complete the remain-
ing fields on the front of the prescription page, sign and stamp, tear off the page 
(the yellow copy remained in the booklet), fetch the prescribed drugs from stor-
age, detach the identification labels from the drug packages and attach them to 
the page, handover the drugs to the patient and collect payment (patient’s share 
of cost). Periodically, pharmacists would send to social security funds lists with 
filled prescriptions attaching the white prescription pages in order to be reim-
bursed. The booklet’s yellow pages served as records for the medication history 
of each patient.
For social security funds, processing prescriptions’ data required resources and 
a dedicated infrastructure. For instance, IKA (the largest social security fund) 
conceptualised a project in 2005 for the electronic processing of the white pre-
scription pages received. A request for proposals was published in 2007 and a 
contract was signed in 2009 for the development of a scanning and processing 
system and its initial operation for 2 years (with a total cost of approximately 6 
million Euro). The system was in place in April 2010 and made possible the scan-
ning, checking and clearing of 2.5 million prescriptions per month (IKA 2009; 
Hararis 2011). The systems that social security funds have developed for scan-
ning, checking and clearing prescriptions are part of the overall prescriptions’ 
installed base and had to be eventually linked to the e-prescription solution (see 
also Sect. 7.3.4).
7.3.3  Information Handling After the Introduction 
of E-Prescription
A graphical representation of the Greek e-prescription service is provided in 
Fig. 7.3. Web-based access is provided to prescribing doctors and pharmacists. 
Access is controlled at the user level (registered users go through a username and 
Fig. 7.2 Paper prescription template
7 Cultivating the Installed Base: The Introduction of e-Prescription in Greece
96
password identification process) and a central repository of all prescriptions is 
maintained nationally. Hospitals access the service over the closed secure network 
Syzefxis, all other healthcare users use their private internet connections. 
Prescribing doctors register key information (including the patient’s name and 
social security number, the diagnosis encoded according to ICD-10, and the medi-
cations prescribed) and then, print a summary page which is handed to the patient. 
Patients can visit any pharmacy in order to obtain prescribed medications. 
Pharmacists take the printed prescription summary page and scan the barcode to 
retrieve the prescription from the national central repository (alternatively they 
can type). Before delivering medications, pharmacists scan the medication pack-
ages’ barcodes which are then matched to prescription details. In case of mis-
match an error message appears on the screen and processing cannot be 
completed.
As with the previous fully paper-based process, pharmacists detach package 
labels and attach them to the prescription printout before handing over medications 
to patients and collecting payment (patient’s share of cost). The bottom part of the 
printout contains designated positions for placing the labels (Fig. 7.4). Periodically, 
pharmacists send to reimbursement authorities lists with the prescriptions they filled 
attaching the printouts that include the identification labels of the medications dis-
pensed. Doctors can use e-prescription for retrieving the full prescriptions’ history 
per patient (pharmacists do not have access to this functionality). Patients do not 
have direct access to e-prescription data.
Patients
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and health centers
Print outs
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Fig. 7.3 E-prescription in Greece
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The e-prescription solution is hosted and maintained by the Greek e-Govern-
ment Centre for Social Security (IDIKA) which has developed it in-house. 
IDIKA is supervised and controlled by the Greek Ministry of Labour, Social 
Security and Welfare; it is mainly financed by the social security funds and is 
responsible for the implementation of information and communication technol-
ogy within the social security sector. E-prescribing was initially piloted in 
October 2010 for patients covered by one specific social security fund (the fund 
for self-employed workers – OAEE). For the piloting of the service almost all 
pharmacists were enrolled along with doctors contracted by the specific fund 
(see also Table 7.1). In January 2011, the service was officially launched and 
three more social security funds were added: the fund for non-public sector sala-
ried employees (IKA) which is the largest in the country, the fund for farmers 
(OGA) and the fund for public servants (OPAD). In 2012 a number of additional 
funds were included: in April, the fund for seafarers (NAT), in May, the fund for 
bank employees (TAITEKO), in November, the fund for employees in the mass 
media (ETAP MME) and in December, the fund for lawyers, engineers, doctors, 
dentists, veterinarians and pharmacists (ETAA). Each addition necessitated 
information exchange with additional fund-specific registries. The establishment 
of the new “National Organisation for Health Services Provision” (EOPYY) 
which started operating in 2012 and gradually assimilated the healthcare insur-
ance schemes of multiple funds (as described in Sect. 7.2.1) helped in the estab-
lishment of common rules but the different funds retained their separate 
registries.
The software development for e-prescription was initially contracted to external 
providers and the first versions launched were not developed in-house. Two low- 
budget contracts were signed with two relatively small software houses (the total 
value including contract extensions for accommodating additional social security 
Fig. 7.4 Prescriptions in Greece: from booklet pages to printouts
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funds was approximately 200,000 euro (ΑΓΓΕΛΟΠΟΎΛΟΥ 2012)). At the begin-
ning of 2012 IDIKA started the in-house development of a new e-prescription solu-
tion which was successfully launched in May 2012 (Sfyroeras 2012b). The new 
in-house development aimed to remedy a series of issues: slow response times and 
concerns about scalability, reliability and usability. It also provided the opportunity 
for expansions and service improvements in a flexible incremental way. The in- 
house development was an interim solution which became necessary as the procure-
ment of the fully-fledged solution through a public tendering process (which was 
initiated in 2010) was delayed due to administrative procedures (Pangalos and 
Asimakopoulos 2015).
7.3.4  System Evolution
The in-house version of e-prescription was launched in May 2012 and included 
enhanced functionality. For instance, it supported the automatic retrieval of basic 
patient information, it provided doctors the option to use multiple affiliations 
(i.e. doctors working both for a private practice and a private clinic), it simpli-
fied the repeat prescriptions’ process and offered improved search functional-
ities. This was the start of a continuous effort for incremental improvements and 
extensions.
 Connections and Extensions
The initial versions of e-prescription were only accessible via web browsers. There 
was no connectivity to the EPRs already in use by doctors or to pharmacy informa-
tion systems (PISs). A major improvement was the publishing of Application 
Programming Interfaces (APIs) that allowed connectivity with doctors’ and phar-
macists’ systems. In the spring of 2012 IDIKA initiated discussions with system 
providers for the APIs that were under development. The APIs were initially tested 
in 400 pharmacies during August 2012 (Πετρόχειλος 2012). They were subse-
quently used by multiple system providers connecting the majority of pharmacies 
(by the end of 2012). In 2015 the APIs for doctors’ EPRs were launched (Tagaris 
2015). The web service APIs developed adhere to REST architectural constraints 
(RESTful APIs) and to the Clinical Document Architecture (CDA) markup standard 
to specify the encoding, structure and semantics of exchanged documents. The 
introduction of the APIs and their exploitation by third party system providers not 
facilitated everyday work for pharmacists and doctors that could now conclude their 
tasks without having to use multiple applications. Figure 7.5 provides an overview 
of the key architectural components for e-prescription (adapted from Asimakopoulos 
(2012)). The figure depicts also the link with the scanning and processing systems 
(for prescription printouts and attached medication labels) of the social security 
funds (Scan SFF).This was an additional extension implemented during the same 
period. The e-prescription team collaborated also with the European project epSOS 
for cross-border interoperability of summaries of electronic health records and 
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e-Prescriptions. Hence, the system can process epSOS friendly prescriptions for 
cross-border healthcare.
The publishing of APIs and the subsequent adaptation of the local EPRs and 
PISs, made possible for doctors and pharmacists to prescribe and dispense medi-
cations without having to shift between the web interface and their local systems. 
Still, doctors that needed not only to prescribe medications but also to order 
diagnostic tests (e.g. diagnostic imaging and blood tests) had to access an addi-
tional system (named e-diagnosis) via a web interface. The electronically sup-
ported process for test ordering is similar to the process for electronic drug 
prescribing: doctors register key information (including the patient’s name and 
social security number, the diagnosis encoded according to ICD-10, and the tests 
ordered) and then print a summary page which is handed to the patient. Patients 
can visit public or private contracted laboratories and diagnostic centers for per-
forming the tests. The e-diagnosis system for test ordering was initially launched 
in October 2010 (for patients covered by the social security fund for public ser-
vants – OPAD) and was developed and maintained by a private software com-
pany. In May 2011, it was decided to simplify use by applying a common user 
authentication scheme for both e-prescription and e-diagnosis but the two sys-
tems were kept separate. After the successful launch of the in-house version of 
e-prescription, IDIKA decided to extend its functionality by including test order-
ing. In January 2013, a new extended version of e-prescription was launched that 
made possible for doctors to prescribe drugs and order tests from within the same 
environment.
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As medications are reimbursed mainly by social security funds, information 
about patients’ affiliation with a specific fund is needed for prescribing medica-
tions (to apply specific reimbursement rules). When e-prescription was first 
introduced the funds were maintaining multiple electronic registries for their 
members and several of those registries were incomplete (for example, most 
registries did not include information about children that are fund beneficiaries 
when one of their parents is a fund member) (Sfyroeras 2012c). Before the 
introduction of e- prescription, doctors and pharmacists would find information 
about a patient’s affiliation by simply looking at the prescriptions’ booklet. The 
booklets also contained information on the status of patients as insured mem-
bers (status relates to the payment of dues to the fund – benefits can only be 
claimed if dues are paid). For the digital process both affiliation and status infor-
mation needed to be electronically available. IDIKA was already responsible for 
the national registry for social security (ΑMΚΑ-ΕMΑΕΣ) that contains national 
social security numbers (AMKA) and basic information per individual (name, 
date of birth, parents’ names). The AMKA registry did not contain information 
about the status of individuals’ relationship with particular funds. In an initia-
tive parallel to e-prescription, a new system named ATLAS that includes a new 
national registry for all healthcare beneficiaries was developed and launched by 
IDIKA in 2014. ATLAS links multiple registries and supports the flow and stor-
age of information on insurance status and social insurance contributions. 
ATLAS is not dedicated to healthcare, it is also meant to support the calculation 
of pensions. This new system was linked to e-prescription in the summer of 
2014.
 Inscriptions of Administrative Rules and Clinical Knowledge
Overall, several rules related to reimbursement are inscribed to e-prescription. 
To start with, the electronic service was designed to replicate the simple con-
straints of the paper-based system that was previously in place. Up to three dif-
ferent medications can be included in one prescription (see also Fig. 7.4); in 
case that more are needed, separate additional prescriptions have to be issued. 
Furthermore, specific rules for medication quantities are also in place – rules 
differ for chronic patients, specific types of medications etc. Since June 2012, 
substance-based prescribing (instead of naming pharmaceutical products) was 
electronically imposed. The classification of active ingredients of medications 
is based on the ATC international classification system. This new rule (sub-
stance-based prescribing) was subsequently relaxed so e-prescribing was read-
justed. Recently, (September 2015) the rule was reintroduced in the system after 
yet another change in the reimbursement regulations. The rules for patients’ 
cost-sharing are also inscribed in the electronic solution (and are being updated 
each time they change). The general rule is that patients contribute 25% of 
medications’ cost but there are many special patient and/or therapy- specific cat-
egories for which the contribution is 10% or even 0% (e.g. chronic patients, 
pregnant women, patients with transplanted organs, etc.). Additionally, there are 
rules for the maximum amounts that patients may pay. Specific constraints on 
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what can be prescribed by doctors according to their specialty are also imple-
mented. Additionally, there are specific rules for prescribing doctors that limit 
the number of prescriptions that can be issued and define upper bounds (caps) 
for the total permitted cost per prescription (since 2013 different methods for 
calculating caps were applied based on simple data analytics e.g. by taking into 
account the prescribing history of individual doctors or specific specialties and 
geographic areas).
The rules inscribed to e-prescription are not only related to costs and reim-
bursements. Therapeutic prescribing protocols for a series of conditions (i.e. 
diagnosis- based prescribing guidelines) have also been electronically imple-
mented. Practically, this means that e-prescribing gradually extended to become 
a decision support tool for doctors. The protocols include medication of “first 
choice”, secondary medications, alternative therapies and rare cases. The medi-
cation options are described on the basis of active substance. These protocols 
are developed by specially appointed committees for condition categories 
defined by the National Organisation for Medicines (EOF) and are approved by 
the Central Health Council (KESY). A total of 160 protocols were developed 
and approved on October 2011. The first protocols were launched within e-pre-
scription in October 2013 (for osteoporosis) and since then, their number has 
been continuously increasing. Up to September 2015 15 different protocols 
were implemented (e.g. for dyslipidaemia, diabetes, arterial hypertension and 
rheumatological conditions) while there are several more under development 
with the aim to be launched before the end of 2015 (for dementia, Parkinson 
disease, epilepsy, chronic obstructive pulmonary disease, chronic bronchitis, 
asthma).
 Working Around Complications in National Plans
The national eHealth roadmap 2006–2015 included a plan for the introduction of 
smart cards in healthcare. The smart cards would be used both for identification 
and authorisation purposes (for patients and healthcare providers) and also for 
storing data (administrative identification, clinical emergency data, prescriptions 
and insurance status) (Angelidis et al. 2010). Small-scale experimentations with 
smart cards for healthcare have been taking place in Greece since the 1990s 
(Karounou and Vassilakopoulos 1995). However, the plan for national level 
deployment of smart cards for health has not been materialised till today. The 
exploration of the whole spectrum of issues that impede the national deployment 
of smart cards for health in Greece is outside the scope of this chapter but we can 
briefly mention issues related to the cost and complexity of extending the existing 
physical infrastructure to include card readers, the need for large-scale organisa-
tional and regulatory adaptations and discussions/disputes around data security 
and data ownership. Nevertheless, as smart health cards are part of the national 
plan the introduction of e-prescription was linked to the use of the cards and that 
was clearly stated when the consultation process for the development of the new 
electronic prescription services was initiated back in 2010 (the use of PKI-based 
smart cards was part of the requirements).
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IDIKA was also involved in small-scale experimentations with smart cards. 
Specifically, a pilot was launched in 2012, in the prefecture of Corinthia were 
2500 individuals insured by the social security fund for municipal employees 
(TYDKY) were provided with personalized smart cards. The pilot was discussed 
in public by IDIKA management: the stated aim was to explore and prepare for 
national scale implementation; it was also announced that IDIKA was planning to 
provide 60.000 smart cards to healthcare providers (covering all prescribing doc-
tors and pharmacies) to enhance e-prescribing security (Πετρόχειλος 2012). The 
use of smart cards for e-prescription was never scaled-up but the pilot showed the 
preparedness of the system to accommodate the national strategy for smart cards 
in healthcare.
The government’s intention for nationwide deployment of smart cards in 
healthcare has been recently reconfirmed and the current plan is to use the cards 
both for healthcare and social benefits (Greek Ministry of the Interior and 
Administrative Reform 2015). Still, the necessary arrangements for nationwide 
deployment are not in place while the e-prescription service is deployed 
 nationally. Given the current situation, the much awaited security enhancement 
of e-prescription is being currently implemented with the introduction of USB 
tokens for healthcare providers (launched in June 2015). While till recently 
access healthcare providers were accessing e-prescription using their user name 
and password, with the introduction of the tokens authentication is performed 
by the combination of the password and the USB token (two-way 
authentication).
The new authentication component is an outcome of the large-scale e- prescription 
project that was awarded to a consortium of companies. As already mentioned the 
in-house developed system is a makeshift solution that was put in place for the 
interim period required to implement the system acquired through a public procure-
ment process. This process was initiated with a public consultation on the design 
and implementation of the e-prescribing system (February–March 2010). This was 
followed by another public consultation which was specific to the implementation 
stages for e-prescription (April 2010). Subsequently, the tendering documents were 
made available for public consultation in April 2011. After that, a two-step tender-
ing process was initiated. An open call for the project (budget Euro 24,6 million – 
duration 36 months) was published in September 2011, four consortia were 
pre-selected (March 2012) and subsequently three of them submitted proposals 
(August 2012). The proposals were evaluated through a lengthy process that culmi-
nated in the contract award (June 2014). The value of the contract was significantly 
lower than the original budget (approx. 40% lower) and the duration was set to 
18 months. The new e-prescription solution was still under development at the time 
of writing.
The overall system evolution described in this section is graphically represented 
in Fig. 7.6. The figure depicts key milestones for the system-in-use and also for the 
public procurement process (for the fully-fledged solution) which has been running 
in parallel.
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7.4  Discussion: Relationship to the Installed Base
7.4.1  Building Upon an Installed Base That Is “Good Enough” 
Without Perpetuating All Weaknesses
Gaps in the backbone of the country’s information infrastructure caused difficulties 
to previous eHealth initiatives. Efforts to harmonize Greek healthcare with European 
“best practices” have repeatedly failed to deliver expected results and some of them 
were abandoned altogether (Economou 2010). Heath data exchange was impeded 
by the lack of a single personal identifier for all Greek residents (each social secu-
rity fund used its own registry with its own identifiers) and the lack of a secure 
network to connect healthcare facilities. A number of recent initiatives with infra-
structural nature filled some of these gaps and created a more favourable environ-
ment for the initiation of e-prescription. A new secure network (Syzefxis) supports 
connections among public institutions and provides gateways to the internet. A 
single national social security number (AMKA) was introduced in October 2009. 
Furthermore, computer-based information systems were present in practically all 
hospitals, primary healthcare units and pharmacies although as recently as 10 years 
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ago this was not the case (see also Sect. 7.2.2). Additionally, standards for informa-
tion codification like the International Classification of Diseases (ICD), the 
Anatomical Therapeutic Chemical (ATC) classification and HL7 Clinical Document 
Architecture (CDA) were already mature and readily available. E-prescription was 
built upon these enabling components and would have been challenged without 
them. Moreover, software architectural styles that allow client-server separation of 
concerns and simplify modular implementation (such as REST) were established. 
So, the development of the software capitalised on relevant technical knowledge 
and experience.
The installed base included also a complicated arrangement of multiple social 
security funds and national actors including the Ministry for Health, the Ministry 
for Labour Social Security and Welfare, the National Organisation for Medicines, 
Doctors and Pharmacists Associations. All these actors were involved by setting 
rules and providing datasets required for digitising the prescribing process. The 
Chief Executive Officer of IDIKA stated in an interview in 2012 that the main chal-
lenges faced were not related to the technical development but rather to the coordi-
nation of all involved actors (Sfyroeras 2012a). He also stated that the lack of 
interoperability among systems and the absence of a national registry for the benefi-
ciaries of healthcare were assessed as showstoppers by some participants during the 
early stages of the initiative. Moreover, he pointed to other key components that 
were missing when the development of e-prescription started: lack of a full list of 
medications available in Greece (not just a list of approved medications), lack of a 
common identifier for medications, lack of a unified doctors’ registry (multiple reg-
istries in place).
Although a number of key components were missing, the new system was not 
merely built upon the installed base perpetuating all of its weaknesses. Instead, sev-
eral initiatives were taken to fill some of the gaps. For example, it would have been 
possible to circumnavigate problems with the national medications’ list by allowing 
users to enter free-text medication descriptions. This would facilitate the circulation 
of messages between doctors and pharmacists but would be an inefficient solution 
for monitoring prescribing practices. The lack of standardised medications’ lists is a 
problem in many other countries including USA were free-texting of e-prescription 
medications is common (Dhavle and Rupp 2014). However, in the Greek case, it was 
decided not to follow such an approach, instead, comprehensive lists were created 
and maintained, new registries were put in place, and new connections were 
implemented.
Overall, a pragmatic approach was adopted: some gaps were filled while others 
were worked around. For instance, for almost 5 years access control to e- prescription 
was rudimentary. Authentication was performed by means of user name and pass-
word. The implementation of mechanisms for two-factor authentication required 
the deployment of a physical infrastructure (smart cards or usb tokens) which was 
costly and logistically demanding. Hence, it was initially postponed and was even-
tually implemented in 2015.
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7.4.2  Handling Continuous Exogenous Shifts 
in the Installed Base
The situation within the installed base kept changing during the 5-years trajectory 
not only as a result of initiatives triggered by the need to put e-prescription in place 
but also because multiple initiatives related to wider reforms within healthcare took 
place. The institutional environment changed with the establishment of the National 
Organisation for Health Services Provision (EOPYY) which started operating in 
2012 and is gradually becoming a single public buyer of healthcare goods and ser-
vices. Additionally, a number of social security funds were merged. Furthermore, 
the distribution of roles and responsibilities among existing actors changed. For 
example, since October 2012 the price lists for medications are issued by the 
National Organisation of Medicines and not by the General Secretariat for Trade. 
The e-prescription service had to adapt to all these changes. Moreover, new poten-
tially useful infrastructural components were created after the initial launching of 
e-prescription. For instance, therapeutic prescribing protocols were made available 
in 2011 and were subsequently progressively included in e-prescription.
Although several of the installed base changes were planned and known in 
advance, e-prescription would not be developed by taking them for granted as it is 
not uncommon to experience delays or even radical twists in national plans (a good 
example is the situation with smart cards for health where there is practically no 
significant advancement till today). Consequently, all decisions had to be based on 
the situation at hand while maintaining openness to accommodate changes. Part of 
the overall uncertain situation was the public procurement process for a fully- 
fledged system which was under way but without any certainty about the timing of 
the delivery. Hence, there was a need to adapt swiftly and cost-effectively since it 
was already known that the system in use would be replaced at some point. What 
was pivotal for this continuous effort to develop and maintain e-prescription through 
adaptations was the clear ownership and dedication by a single institution (IDIKA). 
This institution took the seemingly paradoxical decision to develop in-house at the 
beginning of 2012 a new version (even though the fully-fledged solution was already 
planned), replacing the one that was in place and was already reaching its limits (see 
also Sect. 7.3.3).
7.4.3  Installed Base Cultivation vs. Specifications-Driven 
Development
The tactics described in the two previous sections can be summarised as pragmatic 
exploitation and expansion of a “good enough” installed base, and continuous adap-
tation to exogenous shifts within this base. This can be characterised as a “cultiva-
tion” approach. In that approach, the installed base is not considered as a given and 
stable foundation for further developments that can be fully planned. Instead, the 
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dynamics of this base are acknowledged and hence, interventions are attempted in 
an active interplay with it (Ciborra 1992; Ciborra and Hanseth 1998). Such an 
approach towards the installed base necessitates a requisite technical design that 
supports openness, evolvability and scalability. These were key characteristics of 
the new version of the system that was developed and launched in 2012. Specifically, 
the architectural configuration of the new system (Fig. 7.5) allowed loose coupling 
among components, offered the possibility for continuous new releases and sup-
ported component modifiability to meet changing needs.
A cultivation approach to the installed base entails incremental and evolution-
ary development which is drastically different to the conventional specifications-
driven approach that was followed in the past for national systems. For instance, 
the tax authorities’ system was launched after 7 years of systematic design and 
implementation efforts (Prasopoulou 2012), while the system for social security 
reached countrywide implementation after almost two decades of planning and 
multiple discontinuities in the design and development process (Avgerou and 
McGrath 2007). For the procurement of the fully-fledged system the specifica-
tion-driven approach was also adopted and it would be interesting to know how 
e-prescription would turn out without the prior experience of cultivation for over 
5 years.
7.5  Concluding Remarks
E-prescription played a key role for the establishment of new rules and norms dis-
rupting existing practices within healthcare. The introduction of the new electronic 
service was legitimised by referring to the expected economic impact (Greek 
e-Government Centre for Social Security 2011; Sfyroeras 2012a; Vassilakopoulou 
and Marmaras 2015) and to obligations towards the International Monetary Fund 
and European Institutions. The need for cost containment was undisputed as expen-
diture on pharmaceuticals had reached very high levels: per capita pharmaceutical 
expenses in $ purchasing power parities (PPP) rose from 461 in 2004 to 840 in 2009 
(OECD 2015b). The government managed to reduce the annual bill for pharmaceu-
ticals by €1.8 billion between 2009 and 2013 (OECD 2015a). This significant cost 
cutting cannot be attributed to e-prescription alone. It was the outcome of several 
concurrent measures some of which were related to e-prescription e.g. favouring the 
use of generic medicines via substance-based prescribing and introducing caps per 
prescribing doctor. Additional measures not related to e-prescription include a new 
reference pricing model that takes into account the three EU countries with lowest 
prices, and the renegotiation and reduction of pharmacy and wholesaler margins on 
reimbursed drugs (OECD 2013a; Siskou et al. 2014; Deloitte Centre for Health 
Solutions 2013). The sense of crisis certainly facilitated change nevertheless, this by 
itself is not sufficient. The overall outcome was made possible by a combination of 
institutional leverage, novel technological affordances, and pragmatic tactical 
decisions.
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